Search research articles
Contact Us
Filters
Showing results (431-440 of 472) with videos related to
Page
of 48
Sort By:
Oncogene
|
May 30, 2006
Heparan sulphate proteoglycans are essential for the myeloma cell growth activity of EGF-family ligands in multiple myeloma
K Mahtouk, F W Cremer, T Rème, et al.
Leukemia
|
July 4, 2014
Immunoglobulin light-chain amyloidosis shares genetic susceptibility with multiple myeloma
N Weinhold, A Försti, M I da Silva Filho, et al.
Leukemia
|
August 27, 2013
IMWG consensus on risk stratification in multiple myeloma
W J Chng, A Dispenzieri, C-S Chim, et al.
Annals of Hematology
|
July 8, 2003
Joint HOVON-50/GMMG-HD3 randomized trial on the effect of thalidomide as part of a high-dose therapy regimen and as maintenance treatment for newly diagnosed myeloma patients
H Goldschmidt, P Sonneveld, F W Cremer, et al.
NPJ Breast Cancer
|
November 1, 2019
Randomized phase-II evaluation of letrozole plus dasatinib in hormone receptor positive metastatic breast cancer patients
Devchand Paul, Svetislava J Vukelja, Frankie Ann Holmes, et al.
Bone Marrow Transplantation
|
November 12, 2014
Trends in autologous hematopoietic cell transplantation for multiple myeloma in Europe: increased use and improved outcomes in elderly patients in recent years
H W Auner, R Szydlo, J Hoek, et al.
Leukemia
|
March 23, 2007
Thalidomide in newly diagnosed multiple myeloma: influence of thalidomide treatment on peripheral blood stem cell collection yield
I Breitkreutz, H M Lokhorst, M S Raab, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 4, 2021
Safety and Efficacy of Pembrolizumab in Combination with Acalabrutinib in Advanced Head and Neck Squamous Cell Carcinoma: Phase 2 Proof-of-Concept Study
Matthew H Taylor, Courtney B Betts, Lauren Maloney, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 7, 2021
Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up<sup>†</sup>
M A Dimopoulos, P Moreau, E Terpos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 9, 2022
Corrigendum to "Corrigendum to 'Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up'": [Ann Oncol Volume 33, Issue 1, January 2022, Page 117]
M A Dimopoulos, P Moreau, E Terpos, et al.
Page
of 48
Search research articles
Search
Showing results (431-440 of 472) with videos related to
Sort By:
Page
of 48
Oncogene
|
May 30, 2006
Heparan sulphate proteoglycans are essential for the myeloma cell growth activity of EGF-family ligands in multiple myeloma
K Mahtouk, F W Cremer, T Rème, et al.
Leukemia
|
July 4, 2014
Immunoglobulin light-chain amyloidosis shares genetic susceptibility with multiple myeloma
N Weinhold, A Försti, M I da Silva Filho, et al.
Leukemia
|
August 27, 2013
IMWG consensus on risk stratification in multiple myeloma
W J Chng, A Dispenzieri, C-S Chim, et al.
Annals of Hematology
|
July 8, 2003
Joint HOVON-50/GMMG-HD3 randomized trial on the effect of thalidomide as part of a high-dose therapy regimen and as maintenance treatment for newly diagnosed myeloma patients
H Goldschmidt, P Sonneveld, F W Cremer, et al.
NPJ Breast Cancer
|
November 1, 2019
Randomized phase-II evaluation of letrozole plus dasatinib in hormone receptor positive metastatic breast cancer patients
Devchand Paul, Svetislava J Vukelja, Frankie Ann Holmes, et al.
Bone Marrow Transplantation
|
November 12, 2014
Trends in autologous hematopoietic cell transplantation for multiple myeloma in Europe: increased use and improved outcomes in elderly patients in recent years
H W Auner, R Szydlo, J Hoek, et al.
Leukemia
|
March 23, 2007
Thalidomide in newly diagnosed multiple myeloma: influence of thalidomide treatment on peripheral blood stem cell collection yield
I Breitkreutz, H M Lokhorst, M S Raab, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 4, 2021
Safety and Efficacy of Pembrolizumab in Combination with Acalabrutinib in Advanced Head and Neck Squamous Cell Carcinoma: Phase 2 Proof-of-Concept Study
Matthew H Taylor, Courtney B Betts, Lauren Maloney, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 7, 2021
Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up<sup>†</sup>
M A Dimopoulos, P Moreau, E Terpos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 9, 2022
Corrigendum to "Corrigendum to 'Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up'": [Ann Oncol Volume 33, Issue 1, January 2022, Page 117]
M A Dimopoulos, P Moreau, E Terpos, et al.
Page
of 48